Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.01 – $0.06
32% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.01B | $938.9M | $8.7M | $12.5M | $14.0M | $18.6M | $21.1M | $24.1M |
| Cost of revenue | $868.3M | $819.7M | $7.5M | $9.3M | $10.0M | $13.0M | $14.1M | $16.1M |
| Gross profit | $143.9M | $119.2M | $1.2M | $3.2M | $4.0M | $5.6M | $7.0M | $8.1M |
| Gross margin | 14.2% | 12.7% | 14.1% | 25.8% | 28.6% | 30.1% | 33.3% | 33.5% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $137.9M | $113.1M | $778.3K | $2.7M | $3.5M | $4.9M | $6.3M | $7.2M |
| EBITDA | $152.5M | $126.8M | $1.3M | $3.0M | $3.8M | $5.2M | $7.4M | $7.7M |
| Net income | $138.9M | $111.9M | $1.0M | $3.0M | $3.7M | $5.3M | $7.0M | $8.1M |
| Net margin | 13.7% | 11.9% | 11.7% | 23.8% | 26.5% | 28.6% | 33.2% | 33.4% |
| EPS (diluted) | 0.88 | 0.65 | 0.01 | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 |
Annual figures · source: Financial Modeling Prep
YASHENG GROUP
No one on the platform currently holds HERB.
No tracked institution reports a position in HERB as of their last filing.
| Execution date | Ratio |
|---|---|
| 2022-05-12 | 11-for-10 |
No one on the platform has traded HERB yet.
| $10M |
| — |
| HIRUAmeerex Corporation | $0.00 | -5.26% | $4M | — |
| INDFYIndofood Agri Resources Ltd. | $14.25 | +0.00% | $398M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 1.1× earnings vs its 2.8× historical median P/E.
Fair value ≈ $0.07 · price $0.03 today
Fair-value line = the stock's median historical P/E × earnings. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.